https://www.lifespring.nl/eng https://www.lifespring.nl/eng/nieuws/15/eng-eur-12-8-miljoen-nieuwe-financiering-voor-biotechonderneming-cristal-therapeutics-eng.html https://www.lifespring.nl/eng/nieuws/16/biogeneration-ventures-contributes-to-cristal-therapeutics-eur-12-8-million-financing-round.html https://www.lifespring.nl/eng/nieuws/17/europese-commissie-breidt-marketingvergunning-ruconest-uit-met-zelfstandige-toediening.html https://www.lifespring.nl/eng/nieuws/18/agendia-s-mammaprint-recommended-by-the-2017-st-gallen-international-breast-cancer-guidelines-in-significant-update.html https://www.lifespring.nl/eng/nieuws/23/agendia-s-mammaprint-recommended-by-asco-breast-cancer-guideline-in-focused-update-based-on-landmark-mindact-trial-data.html https://www.lifespring.nl/eng/nieuws/24/pharming-announces-completion-of-its-refinancing-with-a-single-us-100-million-debt-facility-on-improved-commercial-terms.html https://www.lifespring.nl/eng/nieuws/25/pharming-announces-publication-of-ruconest-prophylactic-data-in-the-lancet.html https://www.lifespring.nl/eng/nieuws/26/dutch-mellon-medical-secures-6-million-for-market-introduction-of-major-innovation-in-surgical-suture-technology-single-handed-suturing-using-the-switch.html https://www.lifespring.nl/eng/nieuws/29/pharming-announces-positive-data-from-paediatric-clinical-trial-with-ruconest.html https://www.lifespring.nl/eng/nieuws/30/pharming-group-n-v-and-haei-international-patient-organization-announce-partnership-with-inceptua-medicines-access-for-haei-global-access-program.html https://www.lifespring.nl/eng/nieuws/31/biogeneration-venture-s-portfolio-company-surgvision-acquired-by-bracco-imaging.html https://www.lifespring.nl/eng/nieuws/32/pharming-announces-warrant-exercises-and-conversions-of-its-ordinary-bonds-into-shares-mostly-through-cashless-exercise.html https://www.lifespring.nl/eng/nieuws/33/biogeneration-ventures-fund-iii-reaches-eur-82-million-in-final-close.html https://www.lifespring.nl/eng/nieuws/34/cristal-therapeutics-and-iteos-therapeutics-announce-strategic-partnership-for-the-development-of-immuno-oncology-therapeutic-candidates-using-cristal-s-cripec-nanotech-platform.html https://www.lifespring.nl/eng/nieuws/35/polyganics-announces-birmingham-hand-centre-efficacy-study-of-nerve-conduit-neurolac-in-finger-surgery.html https://www.lifespring.nl/eng/nieuws/36/pharming-announces-completion-of-acquisition-of-all-north-american-commercialisation-rights-for-ruconest-from-valeant.html https://www.lifespring.nl/eng/nieuws/37/pharming-announces-abstract-presented-at-the-american-academy-of-allergy-asthma-immunology-aaaai-annual-meeting-and-sponsorship-of-the-aaaai-foundation-michael-m-frank-md-faaai-lectureship.html https://www.lifespring.nl/eng/nieuws/41/polyganics-achieves-ce-mark-certification-for-liqoseal.html